Considering the different levels and intensities of AsA and GSH production in the different organelles of cell under normal and stress conditions, the regulation of antioxidant enzymes also differs
Lupton MK, Benyamin B, Proitsi P, Nyholt DR, Ferreira MA, Montgomery GW et al (2017) No genetic overlap between circulating iron levels and Alzheimers disease
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
Concurrent liver dysfunction, by impairing copper excretion, further increases the risk of accumulation and adverse cardiovascular events [242, 249]
As of April 2026, the FDA announced removal of injectable GHK-Cu from the Category 2 restricted list, with formal implementation expected July 2026